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ABSTRAK 
KOMPLIKASI  VASKULAR DI KALANGAN PESAKIT 
DIABETIS MELLITUS JENIS 2 DAN HUBUNGKAIT DENGAN 
TEKANAN DARAH TINGGI DAN KADAR KOLESTROL 
TINGGI 
Latar belakang: Penyakit diabetis mellitus jenis 2 adalah penyakit tidak berjangkit 
yang paling utama dikalangan penduduk daerah Marang. Penyakit diabetis mellitus 
jenis 2 adalah sejenis penyakit kronik yang boleh menyebabkan masalah komplikasi 
vaskular. Penyakit tekanan darah tinggi dan penyakit dislipidimia adalah merupakan 
2 jenis morbiditi bersama dengan penyakit diabetis mellitus jenis 2. 
Objektif: Tujuan utama kajian ini dijalankan bagi melihat kehadiran komplikasi 
vascular dan faktor-faktor berkaitan di kalangan pesakit diabetis mellitus jenis 2 di 
daerah Marang dari tahun  2010 sehingga 2016. 
Metodologi: Kajian ini menggunakan kaedah hirisan lentang melibatkan data 
sekunder  pesakit diabetis mellitus jenis 2 yang berdaftar daripada Januari 2010 
sehingga Disember 2016 di dalam pangkalan data Pendaftaran Diabetis Kebangsaan 
atau ―National Diabetic Registry (NDR)‖, unit penyakit tidak berjangkit, Pejabat 
Kesihatan Daerah Marang, Terengganu.  Kesemua pesakit diabetis mellitus jenis 2 
yang berdaftar dengan data lengkap variabel akan dimasukkan ke analisa trend, dan 
500 sampel telah di pilih secara rawak ringkas bagi menggambarkan kadar bilangan 
komplikasi vaskular dan menentukan samada terdapat kaitan di antara kehadiran 
penyakit darah tinggi dan penyakit dislipidimia  dengan belakunya komplikasi 
vaskular. 
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Keputusan:  Seramai enam ribu empat ratus lapan puluh tujuh kes pesakit kencing 
manis jenis 2 telah berdafatar di dalam NDR Marang daripada 2010 sehingga 2016. 
Peringkat umur pesakit kencing manis jenis 2 berumur di antara dari 23 sehingga 93 
tahun. Kadar pesakit wanita adalah lebih tinggi iaitu seramai 362(72.4%) berbanding 
dengan bilangan pesakit lelaki iaitu seramai 138(27.6%). Majoriti pesakit diabetis 
mellitus jenis 2 adalah berbangsa Melayu iaitu seramai 478(95.6%). Majoriti pesakit 
mempunyai indeks jisim badan kumpulan berat badan berlebihan (―Body mass 
index‖ BMI ≥25kg/m²)  iaitu seramai 185(37%). Kadar purata  HbA1c di kalangan 
pesakit diabetis melltus jenis  adalah sebanyak 8.6(2.29). Majoriti pesakit diabetis 
mellitus jenis 2 seramai 431(86.2%) tidak mencapai kadar gula terkawal iaitu nilai 
HbA1c kurang daripada 6.3% . Seramai 340(68%) pesakit mengidap penyakit darah 
tinggi dan seramai 357(71.4%) pesakit mengidap penyakit dislipidimia. Seramai 
seratus lapas belas(23%) pesakit mengalami komplikasi vaskular, samada 
nephropati, retinopati, penyakit jantung, penyakit angin ahmar, ulser kaki diabetis 
dan amputasi anggota badan samada satu atau beberapa komplikasi serentak. 
Komplikasi vaskular yang paling utama berlaku adalah nephropati 59(11.8%) di ikuti 
dengan  retinopati 47(9.6%). Kadar nephropati teringgi di kesan adalah sebanyak 116 
kes pada tahun 2010 dan kemudiannya berlaku naik turun bilangan kes sebelum 
menurun pada tahun 2016. Kadar komplikasi retinopati kekal tinggi dari tahun 2010 
hingga ke 2016. Kadar tertinggi bilangan kes retinopati dikesan adalah 91 kes pada 
tahun 2015 dan kadar yang terendah dikesan adalah sebanyak 61 kes pada tahun 
2013. Kadar penyakit jantung pada mulanya menurun pada tahun 2010 sehingga 
2013 tetapi seterusnya menunjukkan peningkatan yang berterusan daripada tahun 
2014. Bilangan kes ulser kaki diabetis, amputasi anggota badan dan penyakit angin 
ahmar kekal rendah daripada tahun 2010 sehingga 2016. Kehadiran penyakit tekanan 
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darah tinggi(AdjOR 1.750, 95%CI(1.062, 2.886) p-value 0.028) and penyakit 
dislipidimia(AdjOR 1.858, 95%CI: 1.092, 3.160; p-value 0.022 ) didapati ketara 
dikaitkan dengan berlakunya komplikasi vascular. 
Konklusi: Komplikasi vaskular terutamanya nephropati dan retinopati masih lagi 
merupakan masalah kesihatan awam di kalangan pesakit diabetis jenis 2 di daerah 
Marang. Kehadiran bersama penyakit darah tinggi dan penyakit kolestrol tinggi 
menigkatkan lagi risiko untuk berlakunya komplikasi vaskular.  
KATA KUNCI: Penyakit diabetis mellitus jenis 2, penyakit tekananan darah tinggi, 
penyakit dislipidimia, komplikasi vaskular. 
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ABTRACT 
VASCULAR COMPLICATIONS IN TYPE 2 DIABETES MELLITUS 
PATIENTS AND ITS ASSOCIATION WITH HYPERTENSION AND 
DYSLIPIDEMIA 
Background:  Type 2 diabetes mellitus (T2DM) is a common non communicable 
disease among population of Marang district. T2DM is a chronic disease which may 
progress to vascular complications. Hypertension and dyslipidemia are two common 
co morbidities in T2DM. 
Objective: This study aimed to study the occurence of vascular complications and 
their asscoiated factors among T2DM patients in Marang from 2010 to 2016. 
Methodology: This  is a cross sectional design using secondary data  of registered 
T2DM patients  from January 2010 to December 2016 in National Diabetic Registry 
(NDR) database, Non Communicable Disease Unit, District Health Office Marang, 
Terengganu.  All registered T2DM cases with no missing data variable were included 
For trend analysis, and 500 samples were randomly selected to describe the type of 
vascular complication and determine the association between hypertension and 
dyslipidemia with vascular complication.  
Result:  Six thousand four hundred and eighty seven T2DM cases had been 
registered in NDR Marang from 2010 to 2016. The T2DM patient‘s age ranged from 
23 to 93 years old. There were more female 362(72.4%) as compared to male 
patients 138(27.6%). Majority of the T2DM patients were Malay 478(95.6%). 
Majority of the patients were  overweight group (BMI ≥25kg/m²)  185(37%). The 
mean  HbA1c of the T2DM patients was 8.6(2.29). Majority, 431(86.2%) of the 
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T2DM patients did not achieve good glycaemic control target of HbA1c less than 
6.3% . Hypertension present in 340(68%) whereas  357(71.4%) has dyslipidaemia.  
One hundred and eighteen(23%) had vascular complications,either nephropathy, 
retinopathy, ischemic heart disease (IHD), cerebrovascular disease, diabetic foot 
ulcer and amputations as single or multiple complications. 
The most common vascular complications was nephropathy 59(11.8%) followed by 
retinopathy 47(9.6%). The highest detection of nephropathy  were 116  in 2010 
which then fluctuate before reducing back in 2016. Retinopathy complication 
remained high since the year 2010 to 2016. The highest case of retinopathy detected  
were 91 case in 2015 and the lowest detected were 61 case in 2013. IHD reducing 
from 2010 to 2013 but increase steadily again by 2014. Diabetic foot ulcer, 
amputation and cerebro vascular disease remain at lower frequency through out 2010 
to 2016. Presence of hypertension(AdjOR 1.750, 95%CI(1.062, 2.886)  p-value 
0.028) and dyslipidemia(AdjOR 1.858, 95%CI: 1.092, 3.160; p-value 0.022 ) was 
found to be significantly associated with the presence of vascular complication  
Conclusion: Vascular complications especially nephropathy and retinopathy still 
pose a public health problem among T2DM patients in Marang. Presence of 
hypertension and dylipidemia increase the risk of vascular complication.  
KEYWORDS: Type 2 diabetes mellitus, hypertension, dyslipidemia, vascular 
complications. 
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Chapter 1: INTRODUCTION 
1.1 Introduction of Diabetes mellitus 
Diabetes mellitus (DM) is defined as a state of metabolic diseases with an 
elevated blood glucose level (hyperglycaemia). Diabetes is the one of the one the 
most common non communicable disease (NCD) which is currently increasing in 
trend globally. World Health organization (WHO) has estimated that by the year of 
2030, 2.48 million of people in Malaysia will be diagnosed as diabetes mellitus 
(WHO, 2016).  
  DM complications are divided into 2 groups known as acute and chronic 
complications. The acute complications are hypoglycaemia, hyperglycaemic states 
which include diabetic ketoacidosis and hyperglycaemic hyperosmolar state; and 
microbial infections. The chronic complications are divided into macrovascular and 
microvascular. Macrovascular complication comprises the cardiovascular, 
cerebrovascular and peripheral vascular diseases. Microvascular complications are 
retinopathy, nephropathy and neuropathy (Ministry of Health, 2016). 
National Diabetic Registry (NDR) was introduced by Ministry of Health in 
2009. The objectives of NDR are to strengthen the NCD surveillance in Malaysia in 
order  to monitor quality of care, to keep track of the target achievement and clinical 
outcomes annually . Data was initially collected manually in 2009, before web based 
data was introduced in  2011. There were 644 participating health care clinics all 
over in Malaysia. Patient status is regularly updated. The proportions of active 
patients are audited annually, before 31st August each year. This audit is done to 
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obtain clinical and treatment information including clinical investigations result, drug 
dose, complications and co-morbidities. The NDR 2009-20012 report listed 
hypertension (70.1%) and dyslipidaemia (55.1%) as the most common comorbidity. 
The most common complications are nephropathy (7.8%), retinopathy (6.7%), and 
ischemic heart disease (5.3%). (Ministry of Health, 2013). 
1.2 Problem statement & Study rationale 
Data from National Health Morbidity Survey (NHMS) I-IV shows that the 
prevalence of diabetes is increasing in trend from 1986 to 2011.  Despite of the 
clinical practice guideline regular revision, optimal treatment with oral 
hyperglycaemic agent (OHA), early initiation of insulin and increased percentage of 
patient with controlled HbA1c < 6.5%, the number of diabetes with complications 
are still abundant (Ministry of Health, 2013). 
The vascular complications in T2DM  are preventable. Hypertension and 
dyslipidemia is risk factors for diabetes complication which can be controlled with 
lifestyle modification and pharmacotherapy. The burden to patients, their family and 
hospital management can be reduce by early intervention and comprehensive 
diabetic care. Information on the occurrence of vascular complications, types of 
treatment and to the association between hypertension and dyslipidaemia in 
development of vascular complications are able to facilitate effort in reducing 
mortality and morbidity among patients with diabetes. 
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1.3 Research questions 
1. What is the prevalence of vascular complications among type 2 diabetes mellitus 
in Marang Terengganu. 
2. What is the incidence trend of newly detected vascular complications in type 2 
diabetes mellitus diagnosed by year in Marang Terengganu. 
3. Is there any association between hypertension and dyslipidaemia with presence of 
vascular complications. 
1.4 Objectives 
General: 
To study the occurrence of vascular complications among type 2 diabetes mellitus 
patient in Marang for the year of 2010-2016 
  Specific: 
1. To describe the percentage of types vascular complications among type 2 diabetes 
mellitus patient in Marang for the year  2010-2016. 
2. To describe trend of newly detected vascular complications by year from 2010 to 
2016 in Marang. 
3. To determine the association between  the presence of hypertension and 
dyslipidemia in type 2 diabetes mellitus with occurence of vascular complications. 
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1.5 Hypothesis 
The occurence of vascular complications in type 2 diabetes mellitus is associated 
with presence of hypertension and dyslipidaemia. 
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Chapter 2: LITERATURE REVIEW 
2.1 Epidemiology of Diabetes mellitus 
In 2017, the global prevalence of DM were 425 million people , and  is 
estimated to keep on rising to 629 million people by 2045. This figure is estimated 
by using the International Diabetes Federation (IDF) diabetes atlas prevalance 
estimation and including the people aged 20-79 provided by the United Nations 
Population Division. The estimate includes both diagnosed and undiagnosed 
diabetes. The number of DM cases in South East Asia is expected to increase by 2 
times by the year of 2025(Ogurtsova et al., 2017).  
National Health Morbidity Survey (NHMS) has reported that the prevalence of 
DM in Malaysia are increasing in trend. The NHMS  reported the prevalance of DM 
according to two age groups which is above 18 years old and above 30 years old 
group. For the age group above 18 years old, the prevalence of DM were showing an 
increasing trend from 6.3%  in 1986 to 8.3%  in 1996 to 11.6 %  in 2006 and keep on 
increasing upto 15.2% in 2011 and further rised to 17.5% in 2015 (Institute of Public 
Health, 2015). For the age group of above 30 years old, the prevalance of DM had 
shown a faster  increasing in trend which is, 8.3% in 1996 to  14.9% in 2006, and 
further increase to 20.8% in 2011 and keep on increasing to 22.5%  in 2015 (Institute 
of Public Health, 2015). The DM prevalence was different significantly statistically 
between sex where higher prevalence were noted in females at 9.1% (95% CI: 8.4, 
9.8) compared to males at 7.6% (95% CI: 7.0, 8.3). By etchnicity, the highest 
prevalence were among Indians 16.0% (95% CI: 13.7, 18.6), followed by Malays at 
9.0% (95% CI: 8.4, 9.7), Chinese at 7.7% (95% CI: 6.7, 8.9) and other Bumiputras at 
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6.8% (95% CI: 5.3, 8.8).  The prevalence was significantly different between urban 
areas at 8.7% (95% CI: 8.0, 9.3) compared to rural at 7.2% (95% CI: 6.6, 7.9). The 
highest prevalence by states is in Perak at 11.9% (95% CI: 9.9, 14.3), followed by 
Perlis at 10.9% (95% CI: 9.3, 12.7) and Negeri Sembilan at 10.5% (95% CI: 
8.5,12.9); while the lowest is WP Putrajaya at 5.3% (95% CI: 3.3, 8.5)(Institute of 
Public Health, 2015).  
2.2 Screening Of Types 2 Diabetes Mellitus (T2DM) 
Screening is  defined as the process of identifying  asymptomatic individuals who 
are at high risk of a specific disorder and require further investigation or action. It is  
initiated by health care provider and not by a patient's request for help on account of 
a specific complaint. The  screening will gives benefit to the individuals  who are 
being screened. (WHO, 2003).  
Screening  in asymptomatic populations is done when the disease imposed a 
significant health  problem and brought a significant burden on the population. 
Screening will be useful when the natural history of the disease is understood and the 
preclinical asymptomatic stage can be diagnosed with the available, acceptable and 
reliable test. Early detection lead to early treatment  that benefits and cost effective 
compared to those delayed treatment. Screening should be a continous effort and not 
merely a single one-time effort with available facilities and resources  to treat newly 
diagnosed cases (WHO, 2003) 
It is important to screen and diagnose the disease when an individual transitions 
from being disease free to the asymptomatic state is able to reduce the long term 
sequelae. Implementation of lifestyle modification and pharmacological 
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interventions will be able to reduce health-care expenditures ultimately (Abid et al., 
2016). Diabetes can lead to long term effects of  blindness, renal disease, and 
amputations more than any other preventable diseases. The estimated burden on the 
health-care system in Malaysia is around 245 billion ringgit (National Diabetes 
Statistics Report 2017). 
In United State Of America, the screening is done by taking  fasting blood 
glucose, oral glucose tolerance test and A1c. The level of  fasting blood 
glucose  ≥  126  mg/ dL is diagnostic for diabetes and required for retesting. A 75-g 
oral glucose tolerance test will be done and screening is positive if a 2-hour postload 
value of ≥200  mg/dL. Values ≥200 mg/dL are repeated on a different day to confirm 
diagnosis of diabetes. The A1c test is also a valuable tool for diagnosis of diabetes. 
The level of A1c > 5.6 indicates impaired glucose tolerance. (ADA, 2002). In 
Tunisia, a study reported that Hba1c is a reliable tool for screening DM and pre-
diabetes in a high risk population (Oueslati et al., 2017). 
In Malaysia, the guideline of  T2DM management 2015 recommended venous or 
capillary blood using glucometer, followed by fasting blood glucose or random blood 
glucose, oral glucose tolerance test (OGTT) and A1c as the screening method 
(Ministry of Health, 2016). In general population screening should includes 
individuals at risk and  the specific high-risk population. These include the 
symptomatic individuals which has symptoms suggestive of diabetes (tiredness, 
lethargy, polyuria, polydipsia, polyphagia, weight loss, pruritus vulvae, balanitis) as 
well as the asymptomatic individuals. Other  high risk group are adults who are 
overweight or obese (BMI ≥23 kg/m2 or have a waist circumference of  ≥80 cm for 
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women and ≥90 cm for men), and have one or more of the following additional risk 
factors for diabetes: 
i. First-degree relative with diabetes 
ii. History of cardiovascular diseases 
iii. Hypertension (BP ≥140/90 mm Hg or on therapy for hypertension) 
iv. Impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) on previous 
testing 
v. High density lipoprotein (HDL), total cholesterol <0.9 mmol/L or triglycerides 
(TG) >2.8 mmol/L 
vi. Other clinical conditions associated with insulin resistance (e.g. severe obesity 
and acanthosis nigricans) 
vii. Women who delivered a baby weighing ≥4 kg or were diagnosed with gestational 
diabetes mellitus (GDM) 
viii. Women with polycystic ovarian syndrome (PCOS) 
ix. Physical inactivity 
x. Special populations (those who are receiving antiretroviral therapy  or atypical 
antipsychotic drugs.                                                    (Ministry of Health, 2016) 
2.3 Diagnosis Of Types 2 Diabetes Mellitus 
T2DM may be diagnosed based on plasma glucose criteria, either the fasting 
plasma glucose (FPG) or the 2-h plasma glucose (2-h PG) value during a 75-g oral 
glucose tolerance test (OGTT) or A1C criteria (Table 2.3.1). Generally, FPG, 2-h PG 
during 75-g OGTT, and A1C are equally appropriate for diagnostic testing. The 
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similar tests may also be used to screen for and diagnose prediabetes and diabetes 
individuals (ADA, 2018).  
Table 2.3.1 Criteria for diagnosis of diabetes 
FPG ≥ 7.0 mmol/L (126mg/dL).  
 
Fasting is defined as no caloric intake for at least 8 h.
*
 
OR 
2-h PG ≥ 11.1 mmol/L (200 mg/dL)  
 
during OGTT. The test should be performed as described by the WHO, using a 
glucose load containing the equivalent of 75-g anhydrous glucose dissolved in 
water.
*
 
OR 
A1C ≥6.5% (48 mmol/mol). 
 
The test should be performed in a laboratory using a method that is NGSP certified 
and standardized to the DCCT assay.
*
 
OR 
Random plasma glucose ≥11.1 mmol/L (200 mg/dL). 
 
In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis 
 
*
In the absence of unequivocal hyperglycemia, results should be confirmed by repeat testing 
                                                                                           Source:(ADA, 2018)  
In  2011 the WHO Consultation had concluded that HbA1c can be used as a 
diagnostic test for diabetes. An HbA1c of 6.5% is recommended as the cut point for 
diagnosing diabetes. A value less than 6.5% does not exclude diabetes diagnosed 
using glucose tests. In an asymptomatic person, the diagnosis of diabetes should not 
be made from a single abnormal plasma glucose or HbA1c value. The HbA1c or 
plasma glucose test should be repeated and the result with a diabetic range value is 
required, either fasting, from a random (casual) sample, or from the oral glucose 
tolerance test (OGTT). It is advisable to use one test or the other but if both glucose 
and HbA1c are measured and both are ―diagnostic‖ then the diagnosis is confirmed. 
If only one of the test is abnormal, a repeat test is necessary to confirm the diagnosis 
(WHO, 2011) 
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The  Malaysian Clininal Practice Guidelines of management T2DM 5th 
edition 2015 stated that the diagnosis of T2DM should be confirmed by the 
measurement of fasting or random venous plasma glucose or A1c level. Prior to 
therapy initiation, the venous sample for plasma glucose and A1c should be taken 
first. The diagnostic value for type 2 diabetes mellitus based on fasting venous 
plasma glucose are ≥7.0 mmol/L, and for the random venous plasma glucose   ≥11.1 
mmol/L. In symptomatic individual, one abnormal glucose value is diagnostic 
however, in asymptomatic individual, 2 abnormal glucose values are required prior 
to the diagnosis of T2DM (Table 2.3.2).  
Table 2.3.2 Diagnostic Values for Glucose Intolerance and T2DM Based on OGTT. 
OGTT Plasma Glucose Values (mmol/L) 
Category 0-hour 2-hour 
Normal <6.1 <7.8 
IFG 6.1–6.9  
IGT - 7.8–11.0 
DM ≥7.0 ≥11.1 
• IFG = impaired fasting glucose; IGT = impaired glucose tolerance; DM = diabetes mellitus 
• In adolescents, the glucose load in OGTT is based on body weight (1.75 g/kg body weight maximum 
of 75 g).                                                                                                
Source:(Ministry of Health, 2016) 
 
Once the first  fasting venous plasma glucose ≥7.0 mmol/L  or random venous 
plasma glucose ≥11.1 mmol/L, the patient is advise to perform oral glucose tolerance 
test (OGTT) where patient will be given 75g of glucose load prior to the blood 
taking.The normal value of OGTT  0-hour <6.1mmol/L and 2-hour <7.8mmol/L. The 
OGTT value for impaired fasting glucose (IFG) value of 6.1 to 6.9mmol/L and 
impaired glucose tolerance 2-hour post pandrial value of 7.8-11.0 mmol/L. The 
diagnostic value for type 2 diabetes mellitus based on OGTT are 0-hour ≥7.0 
mmol/L, and 2-hour ≥11.1 mmol/L (Table 2.3).  
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Table 2.3.3 Dianostic Value for T2DM Based on Venous Plasma Glucose. 
 Fasting Random 
Venous Plasma Glucose ≥7.0 mmol/L ≥11.1 mmol/L 
• In symptomatic individual, one abnormal glucose value is diagnostic. 
• In asymptomatic individual, 2 abnormal glucose values are required. 
Source:(Ministry of Health, 2016) 
 
The diagnosis of diabetes can be confirmed by taking the A1C. The normal A1c 
value  are <5.6% (38 mmol/mol) .The  diagnostic value for pre diabetes range from 
5.6-6.2% (38-44mmol/mol) and for the diabetes ≥6.3% (45 mmol/mol). If the first 
positive test for asymptomatic patients, then the A1c should be repeated after 4 
weeks. In  symptomatic patients, a single positive test is sufficient for the diagnosis 
of diabetes.(Table 2.4)  
Table 2.3 4 Diagnostic Values for Pre-diabetes and T2DM Based on A1c 
 Normal       Pre-diabetes Diabetes 
A1c <5.6% (38 
mmol/mol) 
5.6-6.2% (38-
44mmol/mol) 
≥6.3% (45 
mmol/mol) 
• A repeat A1c should be done 4 weeks after the first positive test for asymptomatic patients. 
• For symptomatic patients, a single positive test is sufficient.             
Source (Ministry of Health, 2016). 
2.4 Vascular complications in type 2 diabetes mellitus 
Type 2 diabetes mellitus patients have insulin resistance  and usually relative, 
rather than absolute, insulin deficiency.  Prolonged period of hyperglycemia is 
associated with long-term damage and  multiple organ systems failure mainly 
affecting the eyes, nerves, kidneys, and the heart. (DiabetesCare, 2016) 
2.4.1 Pathohysiology of Macrovascular and Microvascular complications  
The function macrovessels is to supply blood to organs, otherwise 
microvessels play important roles in maintaining blood pressure and delivery of 
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nutrient by regulating systems that control the vascular permeability and myogenic 
responses that can adapt blood flow according to local metabolic needs. The 
pathognomonic changes in the microvasculature induces by diabetes,  affect the 
capillary basement membrane by increasing thickness of the  glomerular  arterioles, 
retina, myocardium, skin, and muscle, then will leads to the development of diabetic 
microangiopathy. This thickening will alter the vessel function, and later it will cause 
multiple clinical problems such as hypertension, wound healing delay, and tissue 
hypoxia.  Neovascularization in the vasa vasorum may interconnect macro-and 
microangiopathy, causing platelet rupture and  atherosclerosis. (Orasanu and Plutzky, 
2009). 
 Atherosclerosis is one of the underlying cause for development of 
cardiovascular disease. It  involves a pathologic process initiated at endothelial 
dysfunction, by retention, accumulation, and oxidative modification of lipoprotiens 
in arterial wall (Chapman, 2007). Thomaseth study  stated that micro and 
macrovascular complications has strong association with level of systolic and 
diastolic blood pressure (Thomaseth et al., 2008). The main pathology effects of 
uncontrolled DM involves the vasculature which involving both microvascular and 
macrovascular complications (Orasanu and Plutzky, 2009). The underlying 
pathogenic mechanisms for the development of diabetic nephropathy involve the 
generation of reactive oxygen, accumulation of advanced glycation end product, and 
activation of intracellular signaling molecules such as protein kinase C (Trevisan et 
al., 2006). 
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2.4.2 Prevalence of vascular complications 
The prevalence of diabetic nephropathy was higher in African Americans, 
Asians, and Native Americans as compared to the Caucasians(Gross et al., 2005). A 
study done at Hospital Putrajaya Malaysia showed the prevalence of microvascular 
complications are 75% which is much higher when compared to macrovascular 
complications which is 29% (Hussein et al., 2015). The most common complications 
in Malaysia are nephropathy (7.8%), retinopathy (6.7%), and ischemic heart disease 
(5.3%) (Ministry of Health, 2013). This showed an almost similar pattern in 
Bangladesh where the most common microvascular complications are nephropathy 
(21.3%), neuropathy (16.8%), and retinopathy (12.3%)  (Khanam et al., 2017). 
2.4.3 The associated factors to the development of vascular complications 
Age, body mass index (BMI) and triglyceride are the associated factors to the 
development of vascular complications (Abougalambou et al., 2010). A London 
study stated that obesity, hypertension and lipid abnormalities are the risk factor for 
the development of cardiovascular  diseases  (Jonathan Valabhji  et al. 2002). The 
risk of diabetic complications was strongly associated with raised blood pressure in 
T2DM patients, thus a reduction in systolic blood pressure by 10 mm Hg was 
reported to be able to reduce the risk of any end point related to diabetes upto 12% 
(Adler et al., 2000). Retinopathy or nephropathy is associated with an increased in 
risk for cardiovascular events in type 2 diabetes mellitus patients in New York, 
USA (Rosenson et al., 2011). 
Another study in Italy among type 2 diabetes mellitus with micoalbuminuria 
and hypertension, stated that the glomerular filtration rate (GFR) is determined by 
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glycemic control and blood pressure control (Thomaseth et al., 2008). Ravid et al. 
(1998) shows that the combination of high blood pressure with moderately elevated 
levels of total cholesterol and hemoglobin A1c will leads to the progression of 
diabetic nephropathy and  arteriosclerotic cardiovascular disease. 
 
Another study conducted in Hong Kong stated that coronary artery disease, 
cerebrovascular disease and nephropathy in T2DM patients is related to plasma 
lipid alteration (Chan et al., 2011). In the World Health Organization Multinational 
Study of Vascular Disease in Diabetes, the incidence of myocardial infarction (MI) 
and death from cardiovascular disease (CVD) are associated with retinopathy 
(Fuller et al., 2001).  In the Atherosclerosis Risk in Communities study, retinal 
microvascular abnormalities and generalized arteriolar narrowing was associated 
with increased incidence of clinical stroke (Yatsuya et al., 2010). A study done in  
Faisalabad, Pakistan stated that the prevalance of T2DM are more in age group of 
50-59 years old (Muhammad Hassan et al., 2010). This has also been explored in 
prior studies by prevalance and incidence of diabetes is directly related to 
increasing age (Doria et al., 1999) 
 
Previous studies have shown that the development of  diabetic retinopathy are 
significantly associated with HbA1c, BMI, duration of diabetes and 
microalbuminuria (Chawla et al., 2016). Mohd Ali et al., 2016, reported that age, 
duration of DM, presence of nephropathy and peripheral neuropathy are the 
predictors of  proliferative diabetic retinopathy in T2DM. A study done in Tehran, 
Iran states that increased in development of retinopathy with hypertension, since 
hypertension coexisted in 33.5% of patients with retinopathy (Heydari et al., 2010).  
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Early initiation of insulin is recommended as one of the prevention of vascular 
complications in T2DM patients especially for patients who have poor glycaemic 
control at diagnosis(Ministry of Health, 2009). 
 
 
2.5 Conceptual framework 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type 2 DM Patients attending 
Primary Health Clinic in Marang 
Socio Demographic 
Age 
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Macrovascular  and 
Microvascular 
complications 
Types of treatment 
Diet Control 
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Anti HPT 
 
Clinical Factors 
FBS 
Hba1c 
Durations of 
diabetes 
Body Mass Index 
Abdominal  obesity 
Blood Pressure  
(SBP/DBP) 
Lipid Level 
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Chapter 3: METHODOLOGY 
3.1 Research design 
This study is cross sectional study using surveillance data 
3.2 Reference population 
Type 2 Diabetes Mellitus patients in Marang, Terengganu  
3.3 Source population 
Type 2 Diabetes Mellitus patient registered in NDR from January 2010 till 
December 2016. 
3.4 Inclusion Criteria 
Data of Type 2 Diabetes Mellitus patients registered in NDR from January 2010 till 
December 2016. 
3.5 Exclusion Criteria 
Data with  any missing  variable from NDR. 
17 
 
3.6 Sample size calculation 
Objective 1 : To determine the proportion of vascular complications, the sample 
size will be calculated using the single proportion formula.  
 
 
 
   
 
Table 3.6 1 The value of proportion of vascular proportions 
Variable P n n +20% missing data 
Nephropathy 0.78 263 315 
Retinopathy 0.67 339 406 
IHD 0.53 382 458 
CeVD 0.13 173 207 
Diabetic Foot Ulcer 0.12 162 194 
Amputation 0.09 125 150 
Objective 2: To describe trend of newly detected vascular complications by year.  
All data NDR from January 2010 till December 2016 were used to plot the 
trend. 
Objective 3:  To describe association between presence of hypertension and 
dyslipidemia in type 2 diabetes mellitus with development of vascular complications. 
The sample size will be calculated using PS Sofware for dichotomous 2 proportion. 
The value of proportion of vascular complication  in group with no event variable of 
interest (Po) is taken from previous study (Table 3.6) 
Zα = 1.96 . α=0.05 (95% Condfidence Interval) 
The d = precision  0.05 
The P = prevalance of vascular complications in Malaysia                      
(Ministry of Health, 2013) 
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Table 3.6 2 The value of proportion of vascular complications in relation to 
hypertension and dyslipidemia 
Variable Po P1 m n n = 
nx2+20% 
Study 
HPT only 0.36 0.63 1 53 123 M.Hassan 
et al. 
2010 
Dyslipidemia 
only 
0.5 0.20 1 38 91 Tseng 
L.N. et al. 
2012 
HPT and 
Dyslipidemia 
0.5 0.21 1 42 98 Tseng 
L.N. et al. 
2012 
    P1= estimated proportion of  vascular compliations in expose group  
     Po= proportion of vascular complications in non expose group 
     This study is a cross sectional study,  m=P1:P0 = 1,  α=0.05, power=80% 
 
   
 Therefore 500 data was extracted from NDR considering the biggest sample size 
estimation for objective 1. 
3.7 Sampling Method 
Simple random sampling is done using Microsoft excel program NajibMY4.0. The 
data from NDR with the selected number will be used for this study to answer 
objective 1 and 3. 
3.8 Study area, Time & Duration 
Study Location: Marang, Terengganu 
Study duration: March 2018- April 2018 
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3.9 Research tool & materials 
All data of registered T2DM cases  from January 2010 till December 2016 
was obtained from the Ministry of  Health, Malaysia through National Diabetic 
Registry; an online database system for reporting Diabetic cases from Non 
Communicable Disease Control(NCD) Unit.The data was formated in Microsoft 
Excel later extracted into the data collection form (Appendix 1). Variables 
collected were: 
 a) sex 
 b) Ethnicity 
 c) Age  
d) BMI  
e) SBP 
 f) DBP 
g) HbA1c 
h)   Types of vascular complications and  
j) Co morbidity – Hypertension and dyslipidaemia  
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3.10 Operational definition 
i. Vascular complications:  
Any NDR variable such as retinopathy nephropathy, Ischaemic heart 
disease, cererobvascular disease, diabetic foot ulcer, amputation labelled as 
‗yes‘. 
ii. Retinopathy:  
In NDR the variable retinopathy is labelled as ‗yes‘. It indicate the presence 
of retinal haemorrhages, exudates and macular edema. A non-mydriatic 
fundus camera was used as a screening tool for diabetic retinopathy based on  
two field fundus photo (central and peripheral) assessment. The initial 
assessment should be conducted at the time of diagnosis of T2DM and 
annually.  
iii. Nephropathy:  
In NDR the variable nephropathy is labelled as ‗yes‘. The diagnosis of 
diabetic nephropathy was made clinically by the presence of proteinuria 
(either microalbuminuria or overt proteinuria) at least three consecutive 
readings per year and or serum creatinine>130mmol/L and/or 
GFR<60mil/min.The serum creatinine was used to estimate GFR and stage 
the level of chronic kidney disease(CKD). 
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iv. Ischaemic heart disease (IHD):  
In NDR the variable the ischemic heart disease is labelled as ‗yes‘. It was 
diagnosed by documented angina symptoms and confirmed by 
electrocardigraph(ECG).  
v. Cererobvascular disaease :  
In NDR the variable cerebrovascular disease is labelled as ‗yes‘. It was the 
presence of any sign and symptoms of body weakness or any history of 
hospital admission for cerebrovascular disease.  
vi. Diabetic foot ulcer:  
In NDR the variable  diabetic foot ulcer and amputation is labelled as ‗yes‘. 
Diabetic foot ulcerations are define as any wound or ulcer noted at diabetic 
patients‘ foot. 
vii. Amputation:  
In NDR the variable amputations is labelled as ‗yes‘. It is  define as any 
surgical amputation done on patients limbs secondary to diabetes.  
 
viii.  Hypertension :  
Variable comorbidity HPT ‗yes‘. 
ix. Dyslipidaemia :  
Variable comorbidity Dyslipidaemia ‗yes‘. 
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x. HbA1c:   
The latest HbA1c data entered for each patient.             
3.11  Data collection method: 
This study involved secondary data collection from National Diabetic Registry. The 
required information was extracted anonymously and recorded in data collection 
form (Appendix 1).  
3.12 Statistical analysis 
Data were entered and analysed using the Statistical Program for Social 
Sciences (SPSS version 24). Descriptive statistics will be used to summarise the 
socio-demographic characteristics of subjects. Numerical data will be presented as 
mean and standard deviation. Categorical data will be presented as frequency and 
percentage.  
The percentage of type vascular complications was computed by dividing the 
total number of cases for each complication by the total number of data multiplied by 
100. Trend of newly detected vascular complications by year was illustrated was 
presented using line graph with percentage of patients with vascular complications as 
the Y axis, and number of newly diagnosed as X axis.  
The association between the presence of hypertension and dyslipidaemia in 
with the presence of vascular complications were tested using simple and multiple 
logistic regression. The dependent variable was the presence or absence of vascular 
complications. The independent variable was the presence of hypertension and 
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dyslipidemia. The multivariable regression model was performed by adjusting for 
other possible confounders which were age, sex, ethnicity, HbA1c and body mass 
index. Significant variables or variables with p value less than 0.25 in simple logistic 
regression were used in variable selection for the multiple logistic regression. 
Preliminary main model was obtained from forward LR and backward LR method. 
Correlation matrix showed that there are weak  correlation between variable, hence it 
indicate no multicolinearity was present in the model. All plausible two-way 
interaction were checked betweeen independent variables. Model fitness was tested 
by Hosmer-Lemeshow test, classification table and reciever operation characteristic 
(ROC) curve. The Hosmer Lemeshow test of p-value > 0.005 was taken as not 
significant, which indicate that the model was fit. The findings of final model were 
presented with adjusted odds ratio(OR), its 95% confidence interval(CI) and 
corresponding P-value. The level of significance was set at 0.05. The recommended 
area under ROC curve is at least 0.70. 
3.13 Ethical consideration  
This study was approved by the National Medical Research Register (NMMR) of 
MOH Malaysia with ethical approval number: NMRR-17-3277-39113, and approved 
by the Human Research Ethics Committee of USM (JEPeM), JEpem Code: 
USM/JEpem/17120696. 
1. Privacy and confidentiality 
All data was extracted and entered in SPSS software as anonymous data. Only 
research team members can access the data. Data will be presented as grouped data 
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and will not identify the responders individually. Permission for access into database 
will be obtained from the State Health Director of Terengganu.  
2. Declaration of absence of conflict of interest 
The authors have no conflict of interest on the collection and applicability of the 
data. 
3. Community sensitivities and benefits 
This study preserved confidentiality of collected data surveillance and may facilitates 
the health care plan in reducing morbidity and mortality related to T2DM. 
3.14 Flow chart of study 
 
 
 
 
 
 
                           Figure 3.14: Flow chart of study 
 
 
Data Collection 
Secondary data from NDR online system 
Data entry and analysis using SPSS version 24 
Write up and presentation for final presentation 
Data transfered to Microsoft Excel 
